http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100958678-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C62-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F3-02
filingDate 2008-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100958678-B1
titleOfInvention Method for preparing cis-dimecrotinic acid and salts thereof
abstract The present invention relates to a method for preparing cis (z) -dimecrotic acid and salts thereof suitable for medical use, the present invention relates to a) 4-methyl-7-hydroxycoumarin and sodium hydroxide of formula (IV) After dissolving in a solvent, dimethyl sulfate was added dropwise to react to prepare 4-methyl-7-methoxycoumarin of the general formula (III); b) adding sodium hydroxide to the 4-methyl-7-methoxycoumarin compound to dissolve it, lowering the temperature to room temperature, and then adding dimethyl sulfate dropwise to react to prepare crude dimethacrylic acid; c) providing a method for preparing dimethamic acid magnesium salt of formula (I) by adding magnesium chloride hydrate to the crude dimecrotinic acid produced in the crude dimecrotinic acid step to separate the intermediate material, It is possible to produce the cis-dimethacyanate magnesium salt in one step without purification, which not only makes the manufacturing process simpler, but also reduces the safety and manufacturing cost of the process by using a safe and relatively inexpensive magnesium chloride hydrate as a salt generating material. Only cis (Z) foams suitable for medicinal use are obtained, thereby enabling the production of high purity pharmaceuticals.n n n Dimecrotic acid, Dimecrotic acid, 3- (2,4-dimethoxy-phenyl) -2-butenoic acid, magnesium chloride hydrate
priorityDate 2008-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1915023-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2403752-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100829894-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426385632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID390807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426109635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6445007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453876754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448452169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415956412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419478977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448205592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157623299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451267864
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24644

Total number of triples: 41.